Literature DB >> 9247306

Effect of mutation of cytoplasmic receptor domain and of genistein on transport of acidic fibroblast growth factor into cells.

R Muñoz1, O Klingenberg, A Wiedłocha, A Rapak, P O Falnes, S Olsnes.   

Abstract

Acidic fibroblast growth factor (aFGF) binds to specific transmembrane receptors and is partly transported to a nuclear location. To study this transport we made a kinase-negative mutant of FGF receptor 4 as well as one where the major part of the cytoplasmic receptor domain was deleted, and expressed them in U2OSDr1 cells that lack functional FGF receptors. All receptors mediated endocytic uptake of aFGF. Translocation of the growth factor across cellular membranes was assayed using aFGF with a C-terminal CAAX-motif, which signals addition of a farnesyl group onto the protein once in the cytosol. CAAX-tagged aFGF was farnesylated when incubated with cells containing wild-type or kinase-negative receptors. It was not farnesylated in cells expressing the deleted receptor, or when the incubation was in the presence of genistein. aFGF incubated with cells transfected with wild-type or kinase-negative receptors, but not with the deleted receptor, was partly recovered from the nuclear fraction in the absence, but not in the presence of genistein. The data indicate that the cytoplasmic receptor domain, but not the active kinase, is required for transport of the growth factor into cells, and that genistein inhibits the process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247306     DOI: 10.1038/sj.onc.1201226

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation.

Authors:  X Chen; H Zhou; Y B Liu; J F Wang; H Li; C Y Ung; L Y Han; Z W Cao; Y Z Chen
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

2.  Uptake and intracellular transport of the connective tissue growth factor: a potential mode of action.

Authors:  N A Wahab; H Brinkman; R M Mason
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

3.  Uptake and intracellular transport of acidic fibroblast growth factor: evidence for free and cytoskeleton-anchored fibroblast growth factor receptors.

Authors:  L Citores; J Wesche; E Kolpakova; S Olsnes
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

4.  Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer.

Authors:  Xingyi Guo; Qiuyin Cai; Pingping Bao; Jie Wu; Wanqing Wen; Fei Ye; Wei Zheng; Ying Zheng; Xiao-Ou Shu
Journal:  Cancer       Date:  2016-05-16       Impact factor: 6.860

5.  Ubiquitination of fibroblast growth factor receptor 1 is required for its intracellular sorting but not for its endocytosis.

Authors:  Ellen Margrethe Haugsten; Jedrzej Malecki; Sunniva Maria Stordal Bjørklund; Sjur Olsnes; Jørgen Wesche
Journal:  Mol Biol Cell       Date:  2008-05-14       Impact factor: 4.138

6.  Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1.

Authors:  Jedrzej Małecki; Antoni Wiedłocha; Jørgen Wesche; Sjur Olsnes
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

7.  Clathrin- and dynamin-independent endocytosis of FGFR3--implications for signalling.

Authors:  Ellen Margrethe Haugsten; Malgorzata Zakrzewska; Andreas Brech; Sascha Pust; Sjur Olsnes; Kirsten Sandvig; Jørgen Wesche
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

Review 8.  Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling.

Authors:  Patrycja Szybowska; Michal Kostas; Jørgen Wesche; Ellen Margrethe Haugsten; Antoni Wiedlocha
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

Review 9.  Nuclear localization and function of polypeptide ligands and their receptors: a new paradigm for hormone specificity within the mammary gland?

Authors:  Charles V Clevenger
Journal:  Breast Cancer Res       Date:  2003-04-11       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.